Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France

Bourla, Alexis; Chaneac, E.; Poulet, Emmanuel; Haffen, Emmanuel; Ogorzelec, Laetitia; Guinchard, Christian; Ferreri, Florian; Mouchabac, Stéphane

doi:10.1016/j.encep.2019.07.003

Cited by 10 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous study asked respondents in three U.S. hospitals if they knew how to refer patients for rTMS, and two-thirds of the respondents reported that they did not know [10]. Psychiatrists were poorly informed about, and poorly trained in, rTMS and reported a desire to receive more training and information [11]. By the end of 2015, China had 2,936 mental health institutions and 30,122 licensed psychiatrists [12].…”

Section: Introductionmentioning

confidence: 99%

Knowledge and Attitudes about Transcranial Magnetic Stimulation Among Psychiatrists in China

Deng

Gong

Lin

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive form of brain stimulation. It has been used in many mental health institutions to treat mental disorders worldwide. However, comprehensive knowledge about rTMS is not yet widespread among psychiatrists. The present study assessed psychiatrists’ knowledge and attitudes about rTMS in China and investigated related factors.Methods: A quantitative observational cross-sectional study was conducted using an online survey. The sample consisted of 522 psychiatrists. Multinomial logistic regression and multiple linear regression analyses were used to explore factors that contributed to psychiatrists’ knowledge about rTMS. We also ascertained psychiatrists’ attitudes about rTMS and provide recommendations for the more widespread use of rTMS.Results: The majority of respondents (86.4%) reported having access to rTMS at their institution. A total of 379 psychiatrists (72.6%) knew that rTMS was approved by the United States Food and Drug Administration for treatment-resistant depression. Univariate logistic regression indicated that psychiatrists who were older, had a senior professional title, worked more years, had an onsite clinical rTMS program in their hospital, and received formal training in theory and application (all p < 0.05) were more likely to know that rTMS was approved by the Food and Drug Administration for the treatment of depression. The percentages of respondents who knew most or all indications, the mechanism of action, parameter settings, adverse reactions were 51.9%, 40.2%, 27.4%, and 41.4%. Linear regression showed that formal training in rTMS theory and practice were associated with higher knowledge scores (all p < 0.05). Most of the subjects had negative attitudes about using rTMS to treat mental disorders. When asked about their attitudes about continuing rTMS education, nearly all of the respondents indicated that they were willing to pursue continuing training in rTMS in the future. Conclusions: Many psychiatrists had an insufficient level of knowledge about rTMS and negative attitudes about rTMS. Psychiatrists who had formal rTMS training experience had higher levels of rTMS knowledge. rTMS training and relevant policy making should be strengthened.

show abstract

Section: Introductionmentioning

confidence: 99%

Knowledge and Attitudes about Transcranial Magnetic Stimulation Among Psychiatrists in China

Deng

Gong

Lin

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The survey’s questions were designed after several working sessions between the principal investigator, research staff from Esquirol Hospital Center, pharmacogenetics specialists from the University Hospital Center of Limoges and external consultants, psychiatrists and sociologists, experienced in conducting similar surveys. These questions were partly inspired by previous surveys, particularly with regard to sociodemographic data [ 32 , 33 ] or the limits and risks of pharmacogenetics [ 26 , 30 , 34 ]. The questionnaire was specifically developed for this study and has not yet been validated, but the acceptability model has already been validated [ 32 , 33 ].…”

Section: Methodsmentioning

confidence: 99%

“…As far as we know, there is no study that has evaluated these parameters at the national level in France. The main objective of the present study was therefore to assess the acceptability of pharmacogenetics and pharmacogenetic testing by psychiatrists and psychiatry residents in France using a four domains acceptability model based on International Organisation for Standardization (ISO) and Nielsen models (usefulness, usability, easiness, and risk) that was already used to assess medical technologies acceptability by psychiatrists in two previous studies by Bourla et al [ 32 , 33 ]. Our secondary objectives were to determine the factors associated with and influencing the acceptability score in order to elicit the barriers and pathways likely to impact the integration of this tool in psychiatric care, to determine the factors associated with previous use of pharmacogenetic testing, and to assess more broadly the perception and attitude of psychiatrists towards pharmacogenetics and pharmacogenetic testing, as well as the training received in pharmacogenetics and future training wishes.…”

Section: Introductionmentioning

confidence: 99%

Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey

Laplace

Calvet

Lacroix

et al. 2021

JPM

View full text Add to dashboard Cite

Psychiatric disorder management is based on the prescription of psychotropic drugs. Response to them remains often insufficient and varies from one patient to another. Pharmacogenetics explain part of this variability. Pharmacogenetic testing is likely to optimize the choice of treatment and thus improve patients’ care, even if concerns and limitations persist. This practice of personalized medicine is not very widespread in France. We conducted a national survey to evaluate the acceptability of this tool by psychiatrists and psychiatry residents in France, and to identify factors associated with acceptability and previous use. The analysis included 397 observations. The mean acceptability score was 10.70, on a scale from 4 to 16. Overall acceptability score was considered as low for 3.0% of responders, intermediate for 80.1% and high for 16.9%. After regression, the remaining factors influencing acceptability independently of the others were prescription and training history and theoretical approach. The attitude of our population seems to be rather favorable, however, obvious deficiencies have emerged regarding perceived skills and received training. Concerns about the cost and delays of tests results also emerged. According to our survey, one of the keys to overcoming the barriers encountered in the integration of pharmacogenetics seems to be the improvement of training and the provision of information to practitioners.

show abstract

“…A previous study asked respondents in three U.S. hospitals if they knew how to refer patients for rTMS, and two-thirds of the respondents reported that they did not know [ 10 ]. Psychiatrists were poorly informed about, and poorly trained in, rTMS and reported a desire to receive more training and information [ 11 ]. By the end of 2015, China had 2936 mental health institutions and 30,122 licensed psychiatrists [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

Knowledge and attitudes about transcranial magnetic stimulation among psychiatrists in China

et al. 2020

View full text Add to dashboard Cite

Background Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive form of brain stimulation. It has been used in many mental health institutions to treat mental disorders worldwide. However, comprehensive knowledge about rTMS is not yet widespread among psychiatrists. The present study assessed psychiatrists’ knowledge and attitudes about rTMS in China and investigated related factors. Methods A quantitative observational cross-sectional study was conducted using an online survey. The sample consisted of 522 psychiatrists. Multinomial logistic regression and multiple linear regression analyses were used to explore factors that contributed to psychiatrists’ knowledge about rTMS. We also ascertained psychiatrists’ attitudes about rTMS and provide recommendations for the more widespread use of rTMS. Results The majority of respondents (86.4%) reported having access to rTMS at their institution. A total of 379 psychiatrists (72.6%) knew that rTMS was approved by the United States Food and Drug Administration for treatment-resistant depression. Univariate logistic regression indicated that psychiatrists who were older, had a senior professional title, worked more years, had an onsite clinical rTMS program in their hospital, and received formal training in theory and application (all p < 0.05) were more likely to know that rTMS was approved by the Food and Drug Administration for the treatment of depression. The percentages of respondents who knew most or all indications, the mechanism of action, parameter settings, adverse reactions were 51.9, 40.2, 27.4, and 41.4%. Linear regression showed that formal training in rTMS theory and practice were associated with higher knowledge scores (all p < 0.05). Most of the subjects had negative attitudes about using rTMS to treat mental disorders. When asked about their attitudes about continuing rTMS education, nearly all of the respondents indicated that they were willing to pursue continuing training in rTMS in the future. Conclusions Many psychiatrists had an insufficient level of knowledge about rTMS and negative attitudes about rTMS. Psychiatrists who had formal rTMS training experience had higher levels of rTMS knowledge. rTMS training and relevant policy making should be strengthened.

show abstract

Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France

Cited by 10 publications

References 13 publications

Knowledge and Attitudes about Transcranial Magnetic Stimulation Among Psychiatrists in China

Knowledge and Attitudes about Transcranial Magnetic Stimulation Among Psychiatrists in China

Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey

Knowledge and attitudes about transcranial magnetic stimulation among psychiatrists in China

Contact Info

Product

Resources

About